AVE 16.7% 0.3¢ avecho biotechnology limited

oxymorphone patch m eets phase 1 end points

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    Oxymorphone delivered for 72 hours from single patch application with no adverse events

    Company to proceed with multi-dose and Phase 2 trials in H2 2013


    Hmm I thought they weren't doing Phase 2 trials?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $25 10.00K

Buyers (Bids)

No. Vol. Price($)
66 91668236 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 62801585 14
View Market Depth
Last trade - 15.34pm 23/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.